C5’s 17th Annual Forum on Pharma & Biotech Patent Litigation in Europe will help you understand the latest legal advancements and regulatory developments in the field, offering insights for both litigators and in-house counsel. Attendees can look forward to engaging sessions that explore the evolving implications of the Unified Patent Court (UPC), unpack the nuances of international patent litigation, and unravel the complexities of the EU’s regulatory transformations.

With an agenda designed to highlight the most current challenges and opportunities, including in-depth discussions on the doctrine of equivalents, preliminary injunction proceedings, and global strategies for biosimilars and biologics, the conference is set to be a key convergence point for the who’s who of the European life sciences patent bar. Join us to connect, learn, and shape the future of pharma and biotech patent litigation.

2024 CONFERENCE CHAIRS
Speaker

Joel Coles

Partner
Powell Gilbert LLP

Speaker

Rachel Mumby

Partner
Bristows LLP

Speaker

Ruud van der Velden

Partner
Hogan Lovells

C5 is Proud to Announce, The UPC One Year Later
Speaker

Honorable András Kupecz

Legally Qualified Judge, Central Division, Munich Section
Unified Patent Court

Speaker

Honorable Edger Brinkman

Legally Qualified Judge, Local Division, The Hague
Unified Patent Court

Speaker

Honorable Marije Knijff

District Court Judge
The Hague

Speaker

Prof. Willem Hoyng

Partner
Hoyng Rokh Monegier
Chairman of the UPC Advisory Committee
(Moderator)

PLUS! ESTEEMED IN-HOUSE COUNSEL INCLUDING
Speaker

Frank Landolt

Chief Counsel, IP and Legal
Confo Therapeutics

Speaker

Julia Pike

Global IP Head
Sandoz

Speaker

Karin Pramberger

Head of IP
Swiss Pharma International AG

Speaker

Jiri Slavik

Director, IP
Adalvo

Speaker

Brigitte Carion-Taravella

Principal Patent Counsel, Lead Biologics IP EU Global IP Department, Legal, Ethics & business Integrity
Sanofi

Speaker

Shohta Ueno

Senior Director, Assistant General Counsel – Dispute Resolution
Regeneron

Attend and Gain Insights, Strategies and Global Perspectives

Engage with Industry Pioneers: Featuring a judicial roundtable with Honorable Rian Kalden, András Kupecz, and Edger Brinkman, alongside leading Chief IP Counsel insights, this conference is a hub for high-level intellectual exchange within the European life sciences patent elite

Master the UPC’s Evolving Terrain: Obtain key judicial insights, shedding light on the UPC’s initial impact, procedural details, and strategic influence on European patent litigation

Unravel Regulatory Transformations: Explore the EU’s legislative transformation and see how new directives and regulations are reshaping pharma and biotech litigation strategies

Strategize Across Borders: Sharpen your cross-border litigation strategies with sessions on defending patent rights outside the UPC, navigating China’s patent linkage system, and understanding crucial U.S. legal developments, facing global challenges head-on

C5’S 16 YEAR IMPACT AT PHARMA & BIOTECH EUROPE

1000+

Attendees

330+

Speakers

60+

Sponsors

36

Countries in Attendance

DISTINGUISHED FACULTY

The best that the bar, the bench, and the industry have to offer

MASTER LEVEL STRATEGIES

For litigators and in-house counsel

UNPARALLELED CONNECTIONS

With the “Who’s Who” of the European Life Sciences Patent Bar

WHO ATTENDS
In-Housel Counsel and Executives from Pharmaceutical and Biotech Companies, including:
  • Head of IP
  • Head of Patent Litigation
  • VP-Intellectual property
  • Scientific Director
  • Head of Legal / Legal Affairs
  • Principal Patent Examiner
  • Head of Global Strategy
  • Director Innovation, IP and Portfolio Management
  • R&D Patent manager
  • Associate VP & Director of Technology Licensing & Commercialization
  • Patent Counsel
Law firm attorneys with practices in:
  • Intellectual Property and Patent Law
  • Life Sciences
  • European Patent Law
  • US Patent
OUR PRIOR DELEGATES SAY IT BEST
Quote Icon

The combination of networking opportunities with people from various backgrounds. Concise overview over the most relevant topics.

Dr. Andreas Geissler, LEUKOCARE AG
Quote Icon

Good networking opportunities with in-house Counsel and leading IP law firms. Hot topics, great speakers and convenient number of attendants.

Anna Lopez Lozano, ESTEVE QUÍMICA
Quote Icon

Important subject matters to discuss presented by renowned specialists. An important conference to attend.

Manuel Duraes Rocha, ABREU ADVOGADOS